| Tag | Content |
|---|
EnhancerAtlas ID | HS038-11311 |
Organism | Homo sapiens |
Tissue/cell | ESC_neuron |
Coordinate | chr2:68595050-68596600 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| GATA2 | MA0036.3 | chr2:68595493-68595504 | ACAGATAAGAA | - | 6.14 | | Gata1 | MA0035.3 | chr2:68596361-68596372 | ACAGATAAGGA | - | 6.14 | | Gata1 | MA0035.3 | chr2:68595493-68595504 | ACAGATAAGAA | - | 6.62 |
|
| | Number of super-enhancer constituents: 8 | ID | Coordinate | Tissue/cell |
| SE_09595 | chr2:68588926-68597878 | CD14 | | SE_11074 | chr2:68588629-68625046 | CD20 | | SE_13879 | chr2:68591561-68596636 | CD34_Primary_RO01536 | | SE_20156 | chr2:68589008-68599048 | CD56 | | SE_22763 | chr2:68588979-68622359 | CD8_primiary | | SE_32595 | chr2:68589014-68596842 | GM12878 | | SE_59141 | chr2:68588776-68619027 | Ly3 | | SE_62750 | chr2:68588950-68669253 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr2 | 68595515 | 68595784 | | chr2 | 68595847 | 68596094 |
|
Enhancer Sequence | ACATCTTTGT CCTGTGTCTT GTTTTATGAA ATAATTTTAT TGCAGATAAG TTGTTTTGGG 60
TGGAAAAAAT ATAGCATTAG AAAATGCTGG TGCAGGAATT TTGTCAGGTC AGAAATCTTG 120
GGGTCAATAG TGTTAACTGT AAAACGTTTC TGCTTTTCTT CTGTGCAAGA TGACTGTTGA 180
CATTTCACAA TCCAGGTTTC CTCTTTTGCC TCCTGAATAA GATCTCCAAA TGAAGACAGT 240
GGTTAAGAGG GGGAGGGAAA ATACAAGATT CTGTCATTTT CCAGCTTTTT CATTCCAAGT 300
AACACCCATG TCTCTTTGCC TCAGAGTCTT TCACCTTACT TTTTTGTTTT AAAAAAGAGC 360
ACTTCTAGCC AACCATGGAG CAGCAAGCTG CTATACGAAC ATGACTTCAT TTAATCCTAA 420
CCACCCTATG TGATCCTCAT CTTACAGATA AGAAAACTGA GGTTCACAGA GAATAAGTGA 480
TTCGTCCACA GTGAAACATG TGGCAAGAGG ATGACCTGGG ATTCAAATCC CGGCCTGCCT 540
AACAGCAAAG CCTACCATCT CATTGATCCC AGGCAGCATT CTGAAAGGCA GGCTTGCCCT 600
GGCCTGCAAA AGAACTCACT AGAGCCAGAG CAAGGCACGA ACAAATTGTT TTGTGGGCAA 660
GATTAAGTTT AAAAACCTCA GCCTCCTTTC CTCTCTGTTT AGGGGGTTTC TTTCTGGCCA 720
ATAAACATGT TTGGAAGGTA CTCGAATACC TACTACTGAA TTAGATATGT TCATCATCAT 780
AACTGGAAAA AATGAGAGAA GAGCAAATTA TATGCTCTGC ATAACCTAGA CTCCTCCAAG 840
TCATGTCTCA AACCAGCCTA ATTCCTAGAG GTTTATGGAG CAAGCTGTTG TTTCCAGGAC 900
AACCAACCTC ACAAGCACTT GGCGCAGCAG CGCTGACTCA GAAAGTGGCT GAGGGATTTG 960
GATGTCCTTT GAGGCTGGGA GAAAGCATAG GAATCAGGGT GATGGGAAAG GGAAGGGCAA 1020
GCAGCAGGGA CAGGAAAGGA AAGGGCTGCA GAAAGCTGTG GTAGAAGTGG AAGAGAGCCC 1080
GAGAGTCAGG GTCCTGGCCC AGGAGTTCTT TCCTGGATCT ACCTTGTCTT CTAGGCAGCA 1140
TGAAATAATC TGAAGCGATT TGTGCCTACT GATTCATCAT CACTGTAACA GCTAACGCAT 1200
GTGGTGTTTA CCCTGAAGCA GGAACAGTTC CAAGCATTTC ATGCCTTAAT GCATTTATAC 1260
AGCATACTTA AGACAACTCA ACAAAATGGG GACAATTATT ATCCTTACTT AACAGATAAG 1320
GAGATTGAAG TACAGAGAGG CAAATGGCCT TGTCCAAAGT CACACAGTTA ATAAGTGGCA 1380
GAGCTGGTTT GCAACCCAGC AGTGTGGCCC CAGTATCACG CAGAGCCTAA CCACTTTCTA 1440
TGTGGCCCTC GTGGGCTCGT ACTGCAGTGA CATTCTTTTC CAAAGCACTG TCACCATGAT 1500
GAGGGGTACC CAGGGGAACA TTATGCCAGA GCGACTCCAC AGTGTTGCCT 1550
|
